Publications by authors named "Tamas Pinter"

Claim this Profile
T
The Neutrophil-to-Lymphocyte Ratio May be the Best Serological Biomarker in Predicting Longer Survival in Neoadjuvant Treatment of Triple-Negative Breast Cancer.
Gábor Rubovszky, Norbert Mészáros, Zoltán Mátrai, Ákos Sávolt, Mihály Újhelyi

Cancer Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference-Free Measurement of Urinary Angiotensin-Converting Enzyme (ACE) Activity: Diagnostic and Therapeutic Monitoring Implications.
Attila Ádám Szabó, Enikő Edit Enyedi, Tamás Bence Pintér, Ivetta Siket Mányiné, Csongor Váradi

Biomedicines· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Recent advances in the systemic treatment of head and neck cancers].
Tamás Pintér

Magy Onkol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[First results of comprehensive genomic studies on solid tumours in National Institute of Oncology].
Erika Tóth, Erzsébet Csernák, Andrea Kohánka, László Báthory-Fülöp, Henriett Butz

Magy Onkol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent pneumothoraces caused by a high-grade lung carcinoma with trophoblastic differentiation: a case report.
Márton Csaba, Zsolt Megyesfalvi, László Báthory-Fülöp, Tamás Pintér, László Agócs

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ewing Sarcoma of the Larynx with Thyroid Cartilage Destruction: A Case Report.
Gergely Lerant, Balint Torok, Erika Toth, Tamas Pinter, Maria Godeny

Laryngoscope· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Get reliable laboratory findings - how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?
Attila Ádám Szabó, Enikő Edit Enyedi, István Tibor Altorjay, Péter Hajnal, Tamás Bence Pintér

Clin Chem Lab Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences.
Erika Tóth, Zsófia Kürönya, Edina Soós, Tamás Pintér, Henriett Butz

Acta Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Gilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, Malgorzata Ulanska, Hugues Bourgeois

Breast· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Fertility preservation in female cancer patients.].
Dóra Vesztergom, Borbála Székely, Barbara Hegyi, András Masszi, Tamás Pintér

Orv Hetil· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
László Landherr, Tamás Pintér, Lajos Hornyák, János Révész, Károly Máhr

Magy Onkol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between Tissue Cellularity and Metabolism Represented by Diffusion-Weighted Imaging (DWI) and 18F-FDG PET/MRI in Head and Neck Cancer (HNC).
Omar Freihat, Tóth Zoltán, Tamas Pinter, András Kedves, Dávid Sipos

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC).
Omar Freihat, Zoltán Tóth, Tamás Pintér, András Kedves, Dávid Sipos

Oral Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18).
Richard S Finn, Katalin Boer, Igor Bondarenko, Ravindranath Patel, Tamas Pinter

Breast Cancer Res Treat· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC).
Omar Freihat, Tamas Pinter, András Kedves, Dávid Sipos, Zsolt Cselik

Cancer Imaging· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Paclitaxel containing chemotherapeutic regimens in first line and reintroduced palliative treatment of metastatic cervical cancer].
Tamás Kullmann, István Sipőcz, Kofi Agyemang-Prempeh, Orsolya Barna, Tamás Pintér

Orv Hetil· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.
Gábor Rubovszky, Barna Budai, Erna Ganofszky, Zsolt Horváth, Éva Juhos

Pathol Oncol Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Stereotactic body radiotherapy of liver metastasis: early experience].
Gerda Földi, Csaba Polgár, Zsuzsánna Zongor, Barbara Melles-Bencsik, Gábor Stelczer

Magy Onkol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).
Tamás Pinter, Zandra Klippel, Alvydas Cesas, Adina Croitoru, Jochen Decaestecker

Clin Colorectal Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Does the sidedness determine the first line treatment of irresectable metastatic colorectal cancer?].
Tamás Kullmann, István Sipőcz, Tamás Pintér

Orv Hetil· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effective systemic palliative chemotherapy for intracranial metastases of breast cancer].
István Sipőcz, Tamás Pintér, Zoltán Skaliczky, Tamás Kullmann

Orv Hetil· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
Richard S Finn, John P Crown, Johannes Ettl, Marcus Schmidt, Igor M Bondarenko, Tamas Pinter

Breast Cancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effective palliative chemotherapy in a patient with collecting duct carcinoma of a unilateral kidney associated with anuria. Case report].
Tamás Kullmann, Tamás Pintér, Zsolt Szepesvári, Noémi Kránitz, Stéphane Culine

Orv Hetil· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
Tamás Kullmann, István Sipőcz, Ágnes Csikós, Tamás Pintér

Orv Hetil· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Richard S Finn, John P Crown, Istvan Lang, Katalin Boer, Igor M Bondarenko, Tamas Pinter

Lancet Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis